Drucker, a fellow in Habeners lab in the 1980s, outlined the processing of proglucagon and the biology of GLP-1 action on insulin-producing cells, which led to the development of multiple types of treatments for type 2 diabetes
doi: 10.1021/acschemneuro.6b00207 Summary Keywords CRISPR/Cas9, dopaminergic pathways, gallium nanoparticles, neurodegenerative, neuroglia, Parkinsons Citation Yadav VK, Dhanasekaran S, Choudhary N, Nathiya D, Thakur V, Gupta R, Pramanik S, Kumar P, Gupta N and Patel A (2025) Recent advances in nanotechnology for Parkinsons disease: diagnosis, treatment, and future perspectives
Remember to also include hydrating fruits and vegetables in your diet and choose filtered drinking water whenever possible
Central and peripheral innate and adaptive immunity in Parkinsons disease